These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7307781)

  • 21. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of monoclonal antibodies to study acetylcholine receptors from electric organs, muscle, and brain and the autoimmune response to receptor in myasthenia gravis.
    Lindstrom J; Tzartos S; Gullick W; Hochschwender S; Swanson L; Sargent P; Jacob M; Montal M
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():89-99. PubMed ID: 6586364
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology of the nicotinic acetylcholine receptor.
    Fuchs S
    Curr Top Microbiol Immunol; 1979; 85():1-29. PubMed ID: 114357
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
    Fuchs S
    Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoimmunity to cell membrane receptors.
    De Baets MH; van Breda Vriesman PJ
    Surv Synth Pathol Res; 1985; 4(3):185-215. PubMed ID: 3008292
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acetylcholine receptor; structure and function (author's transl)].
    Kohno M; Hayashi K
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1578-91. PubMed ID: 7029630
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Fulpius BW
    Int Rev Neurobiol; 1983; 24():1-14. PubMed ID: 6197385
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nicotinic cholinergic receptor and myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Aug; 16(4):250-3. PubMed ID: 6315322
    [No Abstract]   [Full Text] [Related]  

  • 31. Myasthenia gravis.
    Newsom-Davis J
    Ann Ital Med Int; 1988; 3 Suppl 1():32-7. PubMed ID: 3152864
    [No Abstract]   [Full Text] [Related]  

  • 32. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.
    Huang D; Shi FD; Giscombe R; Zhou Y; Ljunggren HG; Lefvert AK
    Eur J Immunol; 2001 Jan; 31(1):225-32. PubMed ID: 11265638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Marton LS
    Ann N Y Acad Sci; 1987; 505():451-60. PubMed ID: 2446557
    [No Abstract]   [Full Text] [Related]  

  • 34. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha-Bungarotoxin sensitization in experimental autoimmune myasthenia gravis.
    Kennel PF; Poindron P; Warter JM; Fonteneau P
    Muscle Nerve; 1993 May; 16(5):461-5. PubMed ID: 8390605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism.
    Tarrab-Hazdai R; Abramsky O; Fuchs S
    J Immunol; 1977 Aug; 119(2):702-6. PubMed ID: 886191
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis.
    Conti-Tronconi BM; Morgutti M; Sghirlanzoni A; Clementi F
    Neurology; 1979 Apr; 29(4):496-501. PubMed ID: 571548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis.
    Hossann M; Li Z; Shi Y; Kreilinger U; Büttner J; Vogel PD; Yuan J; Wise JG; Trommer WE
    Protein Expr Purif; 2006 Mar; 46(1):73-84. PubMed ID: 16230023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor--ionic channel complex of Torpedo electroplax and rabbit intercostal muscle.
    Eldefrawi ME; Copio DS; Hudson CS; Rash J; Mansour NA; Eldefrawi AT; Albuguergue EX
    Exp Neurol; 1979 May; 64(2):428-44. PubMed ID: 428517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.